Free Trial
NYSE:A

Agilent Technologies (A) Stock Price, News & Analysis

$154.38
-0.26 (-0.17%)
(As of 01:57 PM ET)
Today's Range
$152.34
$154.65
50-Day Range
$132.44
$154.72
52-Week Range
$96.80
$155.35
Volume
442,157 shs
Average Volume
1.52 million shs
Market Capitalization
$45.24 billion
P/E Ratio
36.76
Dividend Yield
0.61%
Price Target
$141.29

Agilent Technologies MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.59 Rating Score
Upside/​Downside
8.4% Downside
$141.29 Price Target
Short Interest
Healthy
1.61% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.75
Upright™ Environmental Score
News Sentiment
0.64mentions of Agilent Technologies in the last 14 days
Based on 11 Articles This Week
Insider Trading
Selling Shares
$9.22 M Sold Last Quarter
Proj. Earnings Growth
10.73%
From $5.50 to $6.09 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.31 out of 5 stars

Computer And Technology Sector

130th out of 585 stocks

Analytical Instruments Industry

6th out of 27 stocks

A stock logo

About Agilent Technologies Stock (NYSE:A)

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

A Stock Price History

A Stock News Headlines

Padraig McDonnell Assumes Agilent CEO Role
Best Workplaces in Canada 2024: 100-999 employees
See More Headlines
Receive A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Ex-Dividend for 4/24 Dividend
4/01/2024
Dividend Payable
4/24/2024
Today
5/21/2024
Next Earnings (Confirmed)
5/29/2024
Fiscal Year End
10/31/2024

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
CUSIP
00846U10
Employees
18,100
Year Founded
1999

Price Target and Rating

Average Stock Price Target
$141.29
High Stock Price Target
$165.00
Low Stock Price Target
$90.00
Potential Upside/Downside
-8.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.59
Research Coverage
17 Analysts

Profitability

Net Income
$1.24 billion
Pretax Margin
19.78%

Debt

Sales & Book Value

Annual Sales
$6.83 billion
Cash Flow
$6.41 per share
Book Value
$19.98 per share

Miscellaneous

Free Float
N/A
Market Cap
$45.06 billion
Optionable
Optionable
Beta
1.13

Social Links

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

A Stock Analysis - Frequently Asked Questions

Should I buy or sell Agilent Technologies stock right now?

17 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" A shares.
View A analyst ratings
or view top-rated stocks.

What is Agilent Technologies' stock price target for 2024?

17 equities research analysts have issued twelve-month price objectives for Agilent Technologies' stock. Their A share price targets range from $90.00 to $165.00. On average, they anticipate the company's stock price to reach $141.29 in the next year. This suggests that the stock has a possible downside of 8.4%.
View analysts price targets for A
or view top-rated stocks among Wall Street analysts.

How have A shares performed in 2024?

Agilent Technologies' stock was trading at $139.03 on January 1st, 2024. Since then, A stock has increased by 11.0% and is now trading at $154.30.
View the best growth stocks for 2024 here
.

Are investors shorting Agilent Technologies?

Agilent Technologies saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 4,700,000 shares, an increase of 14.1% from the April 15th total of 4,120,000 shares. Based on an average trading volume of 1,550,000 shares, the short-interest ratio is presently 3.0 days. Currently, 1.6% of the company's shares are short sold.
View Agilent Technologies' Short Interest
.

When is Agilent Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 29th 2024.
View our A earnings forecast
.

How can I listen to Agilent Technologies' earnings call?

Agilent Technologies will be holding an earnings conference call on Wednesday, May 29th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) announced its quarterly earnings results on Tuesday, February, 27th. The medical research company reported $1.29 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.07. The medical research company earned $1.66 billion during the quarter, compared to analysts' expectations of $1.59 billion. Agilent Technologies had a net margin of 18.35% and a trailing twelve-month return on equity of 27.09%. The company's quarterly revenue was down 5.5% compared to the same quarter last year. During the same period last year, the firm posted $1.37 EPS.
Read the conference call transcript
.

How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?

Agilent Technologies declared a quarterly dividend on Wednesday, February 21st. Investors of record on Tuesday, April 2nd will be given a dividend of $0.236 per share on Wednesday, April 24th. This represents a $0.94 dividend on an annualized basis and a yield of 0.61%. The ex-dividend date is Monday, April 1st.
Read our dividend analysis for A
.

Is Agilent Technologies a good dividend stock?

Agilent Technologies (NYSE:A) pays an annual dividend of $0.94 per share and currently has a dividend yield of 0.61%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 22.38%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, A will have a dividend payout ratio of 15.44% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for A.

How will Agilent Technologies' stock buyback program work?

Agilent Technologies announced that its board has authorized a share repurchase plan on Monday, January 9th 2023, which permits the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 4.4% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board believes its stock is undervalued.

What guidance has Agilent Technologies issued on next quarter's earnings?

Agilent Technologies updated its second quarter 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of 1.170-1.200 for the period, compared to the consensus estimate of 1.270. The company issued revenue guidance of $1.6 billion-$1.6 billion, compared to the consensus revenue estimate of $1.6 billion.

What is Mike McMullen's approval rating as Agilent Technologies' CEO?

452 employees have rated Agilent Technologies Chief Executive Officer Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among the company's employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), Boeing (BA) and Skyworks Solutions (SWKS).

Who are Agilent Technologies' major shareholders?

Agilent Technologies' stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (10.20%), Price T Rowe Associates Inc. MD (2.91%), Cantillon Capital Management LLC (1.22%), Principal Financial Group Inc. (0.96%), Nordea Investment Management AB (0.95%) and Van ECK Associates Corp (0.95%). Insiders that own company stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Henrik Ancher-Jensen, Jacob Thaysen, Michael R Mcmullen, Michael Tang, Padraig Mcdonnell, Philip Binns and Rodney Gonsalves.
View institutional ownership trends
.

How do I buy shares of Agilent Technologies?

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Agilent Technologies have any subsidiaries?
The following companies are subsidiares of Agilent Technologies: ACEA BIO, ATN Microwave, Accelicon Technologies, Acqiris, Advanced Analytical Technologies, Agilent Raman Spectroscopy, Agilent Technologies Luxco S.à.r.l., Agilent Technologies Luxembourg Holding S.à.r.l., Agilent Technologies Singapore (Global) Pte Ltd., Agilent Technologies Singapore (Holding) Pte. Ltd., Agilent Technologies Singapore (International) Pte. Ltd., Agilent Technologies World Trade Inc., Agilent's Interoperability Certification Labs, American Holographic, Aurora SFC Systems, BIOCIUS Life Sciences, BioTek Instruments, BioTek Instruments LLC, Biosystem Development, Cartagenia, Computational Biology, Dako Denmark, Dako Denmark ApS, Escort Instruments, Genohm, Gradient Design Automation, Halo Genomics, J&W Scientific, Lab901, LaserGen, Lionheart Technologies LLC, Luxcel Biosciensces Ltd., MTS Nano Instruments, MV Technology, Molecular Imaging Corp., Multiplicom, Novelx, Objective Systems Integrators, PXIT, ProZyme Inc, Qosnetics, RVM Scientific, RedSwitch, Resolution Bioscience, SAFCO, Seahorse Bioscience, Silicon Genetics, Stratagene, SynPro, TILL Photonics, ULTRA Scientific, Varian, Velocity11, Wavefront Research, Xpedion Design Systems, Young In Scientific Co. Ltd, Zymed, and iLab Solutions.
Read More
This page (NYSE:A) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners